The parents of a London seven-year-old boy who spent half his life battling cancer are celebrating after he was declared in remission. Jackson Hall was diagnosed in February 2020 with leukaemia after ...
Dr. Filippo Pietrantonio discusses OrigAMI-1 trial data which assessed Rybrevant in mutated, wild-type, non-HER2-amplified metastatic colorectal cancer.
Bicycle Therapeutics' BT8009 offers strong safety and efficacy. Find out why BCYC stock could be a buy, despite recent volatility and awaiting mid-2025 data.